reported that inhibiting SEs by BRD4 inhibitors JQ1 abrogates expression levels of ALDH1A1 and other stem‐related genes, followed by decreasing chemotherapy resistance and tumour relapse in ovarian cancer. The gene discussed is ALDH1A1; the disease is ovarian carcinoma.